Tuesday, 6 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 12, 2026

Exascale Labs Inc. to Combine with D. Boral ARC Acquisition I Corp. to Become Publicly Listed Company

View original at finance.yahoo.com
Exascale Labs Inc. to Combine with D. Boral ARC Acquisition I Corp. to Become Publicly Listed Company Transaction positions Exascale Labs as a publicly listed provider of high-performance, secure, and scalable AI compute infrastructure for enterprise customers…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Exascale has demonstrated consistent monthly revenue growth supported by long-term, recurring customer engagements, and has built a qualified pipeline exceeding $300 million.

    80% confidence
  • Our goal with BCAR was to identify a high-quality, rapidly growing company with strong business fundamentals, supported by a visionary and experienced management team. Hoansoo and his team have built Exascale into a next-generation AI infrastructure solution and have set themselves apart in the industry by engaging blue-chip customers and multi-year contracts with an impressive backlog. We believe Exascale is uniquely positioned for continued value creation in the growing AI adjacent landscape, and we are excited to partner with them to bring this business to the public markets and support their long-term vision.

    80% confidence
  • This milestone is a testament to Exascale's vision of making advanced AI computing power accessible on a global scale. By partnering with BCAR to become a public company, we expect to accelerate our growth plans, invest further in our cutting-edge technology, and expand our services to meet the unprecedented demand for AI infrastructure. We believe this transaction will position us to create long-term value for our customers and shareholders as we execute on our strategy.

    80% confidence
  • The global Artificial Intelligence Infrastructure Market was valued at approximately $135.81 billion in 2024 and is projected to grow from approximately $182.07 billion in 2025 to approximately $394.46 billion by 2030.

    80% confidence
  • The proposed business combination gives Exascale approximately $500 million in pre-transaction equity value.

    80% confidence
  • Exascale's business model is driven by an increasingly diversified base of long-dated, contracted infrastructure engagements across enterprise, academia, AI-native customers, developers, and decentralized AI protocols, typically involving dedicated compute capacity deployed over multi-year periods.

    80% confidence
  • The closing of the proposed business combination is expected to be in the second quarter of 2026, subject to shareholders' approval and the satisfaction of customary closing conditions.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com